BridgeMD

Sign in

Overweight Obesity clinical trials

Explore recruiting overweight obesity clinical trials.

Recruiting overweight obesity studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Overweight Obesity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A randomized, double-blind, placebo-controlled proof-of-concept parallel group clinical trial to investigate the efficacy, safety and tolerability of weekly subcutaneous (SC) dosing of CK-0045 in participants with overweight / obesity and Type 2 diabetes

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A 52 week prospective randomized controlled study to investigate the effect of intramuscular testosterone undecanoate supplementation vs placebo on intrahepatic fat content in obese men with uncontrolled type 2 diabetes (T2DM) suffering from hypogonadism with a subsequent 108 week open label phase to investigate long term effects on lipid distribution and cardiometabolic parameters in all participating men.

Austria

Therapeutic use (Phase IV) EU CTIS Study details

SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyngioma in children aged 12 to 17 years

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Overweight Obesity trials by city

Overweight Obesity in Toronto Overweight Obesity in Vancouver Overweight Obesity in Montreal Overweight Obesity in Calgary Overweight Obesity in Edmonton Overweight Obesity in Ottawa Overweight Obesity in Winnipeg Overweight Obesity in Quebec City Overweight Obesity in Hamilton Overweight Obesity in Kitchener Overweight Obesity in London Overweight Obesity in Halifax Overweight Obesity in New York Overweight Obesity in Los Angeles Overweight Obesity in Chicago Overweight Obesity in Houston